TY - JOUR
T1 - Neuralgisk amyotrofi
AU - Skaastrup, Kristoffer N
AU - Graffe, Carolina C
AU - Frahm-Falkenberg, Siska
AU - Krarup, Christian
AU - Jakobsen, Johannes K
N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.
PY - 2025/6/23
Y1 - 2025/6/23
N2 - This review provides an overview of neuralgic amyotrophy (NA) to improve treatment and collaboration. The disorder is a neuropathy characterized by acute onset of asymmetric severe pain, paresis, atrophy, and sensory deficits followed by prolonged remission. The incidence of NA is likely higher than previously assumed. Initial treatment includes a combination of long-lasting NSAIDs and slow-release opioids, while corticosteroids may be considered in severe cases. Physical therapy is reserved for chronic phase treatment. Electrophysiological tests and ultrasound may aid the clinical diagnosis.
AB - This review provides an overview of neuralgic amyotrophy (NA) to improve treatment and collaboration. The disorder is a neuropathy characterized by acute onset of asymmetric severe pain, paresis, atrophy, and sensory deficits followed by prolonged remission. The incidence of NA is likely higher than previously assumed. Initial treatment includes a combination of long-lasting NSAIDs and slow-release opioids, while corticosteroids may be considered in severe cases. Physical therapy is reserved for chronic phase treatment. Electrophysiological tests and ultrasound may aid the clinical diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=105009651407&partnerID=8YFLogxK
U2 - 10.61409/V09240628
DO - 10.61409/V09240628
M3 - Review
C2 - 40546065
SN - 0041-5782
VL - 187
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
IS - 26
M1 - V09240628
ER -